nodes	percent_of_prediction	percent_of_DWPC	metapath
Caffeine—CYP2D6—Alzheimer's disease	0.212	1	CbGaD
Caffeine—CYP2D6—Rivastigmine—Alzheimer's disease	0.0688	0.215	CbGbCtD
Caffeine—CYP2C9—Donepezil—Alzheimer's disease	0.0602	0.188	CbGbCtD
Caffeine—CYP2D6—Donepezil—Alzheimer's disease	0.055	0.172	CbGbCtD
Caffeine—CYP3A4—Rivastigmine—Alzheimer's disease	0.0438	0.136	CbGbCtD
Caffeine—CYP2D6—Galantamine—Alzheimer's disease	0.0355	0.111	CbGbCtD
Caffeine—CYP3A4—Donepezil—Alzheimer's disease	0.035	0.109	CbGbCtD
Caffeine—CYP3A4—Galantamine—Alzheimer's disease	0.0225	0.0703	CbGbCtD
Caffeine—PIK3CD—blood vessel—Alzheimer's disease	0.00545	0.0514	CbGeAlD
Caffeine—PIK3CB—blood vessel—Alzheimer's disease	0.00475	0.0448	CbGeAlD
Caffeine—PIK3CA—blood vessel—Alzheimer's disease	0.0047	0.0443	CbGeAlD
Caffeine—ATM—embryo—Alzheimer's disease	0.00366	0.0345	CbGeAlD
Caffeine—Cerebral haemorrhage—Donepezil—Alzheimer's disease	0.00359	0.0295	CcSEcCtD
Caffeine—Cerebral haemorrhage—Memantine—Alzheimer's disease	0.00326	0.0268	CcSEcCtD
Caffeine—PIK3CD—embryo—Alzheimer's disease	0.00325	0.0306	CbGeAlD
Caffeine—ATM—telencephalon—Alzheimer's disease	0.00298	0.0281	CbGeAlD
Caffeine—PIK3CD—forebrain—Alzheimer's disease	0.00287	0.0271	CbGeAlD
Caffeine—PIK3CB—embryo—Alzheimer's disease	0.00283	0.0267	CbGeAlD
Caffeine—PRKDC—telencephalon—Alzheimer's disease	0.00282	0.0266	CbGeAlD
Caffeine—PIK3CA—embryo—Alzheimer's disease	0.0028	0.0264	CbGeAlD
Caffeine—PIK3CD—telencephalon—Alzheimer's disease	0.00264	0.0249	CbGeAlD
Caffeine—PIK3CB—forebrain—Alzheimer's disease	0.00251	0.0236	CbGeAlD
Caffeine—PIK3CA—forebrain—Alzheimer's disease	0.00248	0.0234	CbGeAlD
Caffeine—PIK3CB—telencephalon—Alzheimer's disease	0.0023	0.0217	CbGeAlD
Caffeine—PIK3CA—telencephalon—Alzheimer's disease	0.00228	0.0215	CbGeAlD
Caffeine—Accidental injury—Donepezil—Alzheimer's disease	0.00224	0.0184	CcSEcCtD
Caffeine—Creatinine increased—Donepezil—Alzheimer's disease	0.00209	0.0171	CcSEcCtD
Caffeine—Accidental injury—Memantine—Alzheimer's disease	0.00204	0.0167	CcSEcCtD
Caffeine—Injury—Galantamine—Alzheimer's disease	0.00202	0.0166	CcSEcCtD
Caffeine—Creatinine increased—Memantine—Alzheimer's disease	0.00189	0.0156	CcSEcCtD
Caffeine—ATM—nervous system—Alzheimer's disease	0.00176	0.0166	CbGeAlD
Caffeine—Sepsis—Donepezil—Alzheimer's disease	0.00172	0.0142	CcSEcCtD
Caffeine—ATM—central nervous system—Alzheimer's disease	0.00169	0.016	CbGeAlD
Caffeine—ATM—cerebellum—Alzheimer's disease	0.00165	0.0156	CbGeAlD
Caffeine—Gastritis—Galantamine—Alzheimer's disease	0.00165	0.0135	CcSEcCtD
Caffeine—Urine output increased—Memantine—Alzheimer's disease	0.00163	0.0134	CcSEcCtD
Caffeine—Pulmonary oedema—Memantine—Alzheimer's disease	0.00161	0.0132	CcSEcCtD
Caffeine—Urine output increased—Rivastigmine—Alzheimer's disease	0.0016	0.0131	CcSEcCtD
Caffeine—Pulmonary oedema—Rivastigmine—Alzheimer's disease	0.00157	0.0129	CcSEcCtD
Caffeine—Injury—Donepezil—Alzheimer's disease	0.00157	0.0129	CcSEcCtD
Caffeine—PRKDC—cerebellum—Alzheimer's disease	0.00156	0.0148	CbGeAlD
Caffeine—Sepsis—Memantine—Alzheimer's disease	0.00156	0.0129	CcSEcCtD
Caffeine—PIK3CD—nervous system—Alzheimer's disease	0.00156	0.0147	CbGeAlD
Caffeine—Sepsis—Rivastigmine—Alzheimer's disease	0.00153	0.0126	CcSEcCtD
Caffeine—ADORA2A—forebrain—Alzheimer's disease	0.00152	0.0143	CbGeAlD
Caffeine—PIK3CD—central nervous system—Alzheimer's disease	0.0015	0.0142	CbGeAlD
Caffeine—Hypoglycaemia—Donepezil—Alzheimer's disease	0.00148	0.0121	CcSEcCtD
Caffeine—PIK3CD—cerebellum—Alzheimer's disease	0.00147	0.0138	CbGeAlD
Caffeine—Deafness—Memantine—Alzheimer's disease	0.00146	0.012	CcSEcCtD
Caffeine—Hyperglycaemia—Galantamine—Alzheimer's disease	0.00145	0.0119	CcSEcCtD
Caffeine—Gastrointestinal haemorrhage—Donepezil—Alzheimer's disease	0.00144	0.0118	CcSEcCtD
Caffeine—Deafness—Rivastigmine—Alzheimer's disease	0.00143	0.0118	CcSEcCtD
Caffeine—Injury—Memantine—Alzheimer's disease	0.00142	0.0117	CcSEcCtD
Caffeine—Renal failure—Galantamine—Alzheimer's disease	0.00141	0.0116	CcSEcCtD
Caffeine—ADORA2A—telencephalon—Alzheimer's disease	0.0014	0.0132	CbGeAlD
Caffeine—Injury—Rivastigmine—Alzheimer's disease	0.00139	0.0114	CcSEcCtD
Caffeine—Irritability—Donepezil—Alzheimer's disease	0.00138	0.0113	CcSEcCtD
Caffeine—PIK3CB—nervous system—Alzheimer's disease	0.00136	0.0128	CbGeAlD
Caffeine—Blood creatinine increased—Donepezil—Alzheimer's disease	0.00135	0.0111	CcSEcCtD
Caffeine—RYR1—nervous system—Alzheimer's disease	0.00135	0.0127	CbGeAlD
Caffeine—PIK3CA—nervous system—Alzheimer's disease	0.00135	0.0127	CbGeAlD
Caffeine—ATM—brain—Alzheimer's disease	0.00134	0.0127	CbGeAlD
Caffeine—Hypoglycaemia—Memantine—Alzheimer's disease	0.00134	0.011	CcSEcCtD
Caffeine—Dry skin—Donepezil—Alzheimer's disease	0.00132	0.0109	CcSEcCtD
Caffeine—Hypoglycaemia—Rivastigmine—Alzheimer's disease	0.00131	0.0108	CcSEcCtD
Caffeine—ADORA1—forebrain—Alzheimer's disease	0.00131	0.0124	CbGeAlD
Caffeine—PIK3CB—central nervous system—Alzheimer's disease	0.00131	0.0124	CbGeAlD
Caffeine—Gastrointestinal haemorrhage—Memantine—Alzheimer's disease	0.00131	0.0108	CcSEcCtD
Caffeine—RYR1—central nervous system—Alzheimer's disease	0.0013	0.0122	CbGeAlD
Caffeine—PIK3CA—central nervous system—Alzheimer's disease	0.0013	0.0122	CbGeAlD
Caffeine—Haemoglobin—Galantamine—Alzheimer's disease	0.00129	0.0106	CcSEcCtD
Caffeine—Haemorrhage—Galantamine—Alzheimer's disease	0.00129	0.0106	CcSEcCtD
Caffeine—Gastrointestinal haemorrhage—Rivastigmine—Alzheimer's disease	0.00128	0.0105	CcSEcCtD
Caffeine—PIK3CB—cerebellum—Alzheimer's disease	0.00128	0.0121	CbGeAlD
Caffeine—Gastritis—Donepezil—Alzheimer's disease	0.00128	0.0105	CcSEcCtD
Caffeine—PRKDC—brain—Alzheimer's disease	0.00127	0.012	CbGeAlD
Caffeine—RYR1—cerebellum—Alzheimer's disease	0.00127	0.0119	CbGeAlD
Caffeine—PIK3CA—cerebellum—Alzheimer's disease	0.00127	0.0119	CbGeAlD
Caffeine—Irritability—Memantine—Alzheimer's disease	0.00125	0.0103	CcSEcCtD
Caffeine—Blood creatinine increased—Memantine—Alzheimer's disease	0.00123	0.0101	CcSEcCtD
Caffeine—ADORA1—telencephalon—Alzheimer's disease	0.00121	0.0114	CbGeAlD
Caffeine—Dry skin—Memantine—Alzheimer's disease	0.0012	0.00986	CcSEcCtD
Caffeine—Cardiac disorder—Galantamine—Alzheimer's disease	0.00119	0.00981	CcSEcCtD
Caffeine—PIK3CD—brain—Alzheimer's disease	0.00119	0.0112	CbGeAlD
Caffeine—Dry skin—Rivastigmine—Alzheimer's disease	0.00117	0.00964	CcSEcCtD
Caffeine—Immune system disorder—Galantamine—Alzheimer's disease	0.00116	0.00955	CcSEcCtD
Caffeine—Gastritis—Memantine—Alzheimer's disease	0.00116	0.00952	CcSEcCtD
Caffeine—Gastritis—Rivastigmine—Alzheimer's disease	0.00113	0.00931	CcSEcCtD
Caffeine—Hyperglycaemia—Donepezil—Alzheimer's disease	0.00112	0.00923	CcSEcCtD
Caffeine—Malnutrition—Galantamine—Alzheimer's disease	0.00112	0.0092	CcSEcCtD
Caffeine—Infestation NOS—Donepezil—Alzheimer's disease	0.00111	0.00913	CcSEcCtD
Caffeine—Infestation—Donepezil—Alzheimer's disease	0.00111	0.00913	CcSEcCtD
Caffeine—Renal failure—Donepezil—Alzheimer's disease	0.00109	0.00897	CcSEcCtD
Caffeine—Nervousness—Galantamine—Alzheimer's disease	0.00109	0.00894	CcSEcCtD
Caffeine—PIK3CB—brain—Alzheimer's disease	0.00104	0.00981	CbGeAlD
Caffeine—Agitation—Galantamine—Alzheimer's disease	0.00103	0.00846	CcSEcCtD
Caffeine—RYR1—brain—Alzheimer's disease	0.00103	0.00971	CbGeAlD
Caffeine—PIK3CA—brain—Alzheimer's disease	0.00103	0.00971	CbGeAlD
Caffeine—Hyperglycaemia—Memantine—Alzheimer's disease	0.00102	0.00838	CcSEcCtD
Caffeine—Infestation—Memantine—Alzheimer's disease	0.00101	0.00829	CcSEcCtD
Caffeine—Infestation NOS—Memantine—Alzheimer's disease	0.00101	0.00829	CcSEcCtD
Caffeine—Haemoglobin—Donepezil—Alzheimer's disease	0.001	0.00823	CcSEcCtD
Caffeine—Hyperglycaemia—Rivastigmine—Alzheimer's disease	0.000998	0.0082	CcSEcCtD
Caffeine—Haemorrhage—Donepezil—Alzheimer's disease	0.000997	0.00819	CcSEcCtD
Caffeine—Renal failure—Memantine—Alzheimer's disease	0.000992	0.00815	CcSEcCtD
Caffeine—ADORA2B—nervous system—Alzheimer's disease	0.000991	0.00934	CbGeAlD
Caffeine—Infestation—Rivastigmine—Alzheimer's disease	0.000987	0.00811	CcSEcCtD
Caffeine—Infestation NOS—Rivastigmine—Alzheimer's disease	0.000987	0.00811	CcSEcCtD
Caffeine—Convulsion—Galantamine—Alzheimer's disease	0.000971	0.00797	CcSEcCtD
Caffeine—Renal failure—Rivastigmine—Alzheimer's disease	0.00097	0.00797	CcSEcCtD
Caffeine—PDE4B—forebrain—Alzheimer's disease	0.00097	0.00914	CbGeAlD
Caffeine—Hypertension—Galantamine—Alzheimer's disease	0.000967	0.00795	CcSEcCtD
Caffeine—ADORA2B—central nervous system—Alzheimer's disease	0.000954	0.00899	CbGeAlD
Caffeine—ADORA2B—cerebellum—Alzheimer's disease	0.000932	0.00879	CbGeAlD
Caffeine—Haemoglobin—Memantine—Alzheimer's disease	0.00091	0.00748	CcSEcCtD
Caffeine—Haemorrhage—Memantine—Alzheimer's disease	0.000906	0.00744	CcSEcCtD
Caffeine—Nervous system disorder—Galantamine—Alzheimer's disease	0.000897	0.00737	CcSEcCtD
Caffeine—Tachycardia—Galantamine—Alzheimer's disease	0.000892	0.00733	CcSEcCtD
Caffeine—PDE4B—telencephalon—Alzheimer's disease	0.000892	0.00841	CbGeAlD
Caffeine—Haemoglobin—Rivastigmine—Alzheimer's disease	0.00089	0.00731	CcSEcCtD
Caffeine—Skin disorder—Galantamine—Alzheimer's disease	0.000888	0.0073	CcSEcCtD
Caffeine—Haemorrhage—Rivastigmine—Alzheimer's disease	0.000886	0.00728	CcSEcCtD
Caffeine—Malnutrition—Donepezil—Alzheimer's disease	0.000868	0.00713	CcSEcCtD
Caffeine—Nervousness—Donepezil—Alzheimer's disease	0.000843	0.00693	CcSEcCtD
Caffeine—Cardiac disorder—Memantine—Alzheimer's disease	0.00084	0.0069	CcSEcCtD
Caffeine—ADORA2A—nervous system—Alzheimer's disease	0.000824	0.00777	CbGeAlD
Caffeine—Cardiac disorder—Rivastigmine—Alzheimer's disease	0.000822	0.00675	CcSEcCtD
Caffeine—Immune system disorder—Memantine—Alzheimer's disease	0.000818	0.00672	CcSEcCtD
Caffeine—Agitation—Donepezil—Alzheimer's disease	0.000798	0.00655	CcSEcCtD
Caffeine—ADORA2A—central nervous system—Alzheimer's disease	0.000794	0.00748	CbGeAlD
Caffeine—Gastrointestinal disorder—Galantamine—Alzheimer's disease	0.000789	0.00648	CcSEcCtD
Caffeine—Malnutrition—Memantine—Alzheimer's disease	0.000788	0.00648	CcSEcCtD
Caffeine—ADORA2A—cerebellum—Alzheimer's disease	0.000776	0.00731	CbGeAlD
Caffeine—Malnutrition—Rivastigmine—Alzheimer's disease	0.000771	0.00634	CcSEcCtD
Caffeine—Nervousness—Memantine—Alzheimer's disease	0.000766	0.00629	CcSEcCtD
Caffeine—CYP1B1—telencephalon—Alzheimer's disease	0.000764	0.00721	CbGeAlD
Caffeine—ADORA2B—brain—Alzheimer's disease	0.000757	0.00714	CbGeAlD
Caffeine—Convulsion—Donepezil—Alzheimer's disease	0.000752	0.00618	CcSEcCtD
Caffeine—Hypertension—Donepezil—Alzheimer's disease	0.00075	0.00616	CcSEcCtD
Caffeine—Nervousness—Rivastigmine—Alzheimer's disease	0.000749	0.00615	CcSEcCtD
Caffeine—Agitation—Memantine—Alzheimer's disease	0.000724	0.00595	CcSEcCtD
Caffeine—ADORA1—nervous system—Alzheimer's disease	0.000712	0.00671	CbGeAlD
Caffeine—Agitation—Rivastigmine—Alzheimer's disease	0.000709	0.00582	CcSEcCtD
Caffeine—Infection—Donepezil—Alzheimer's disease	0.000704	0.00578	CcSEcCtD
Caffeine—Nervous system disorder—Donepezil—Alzheimer's disease	0.000695	0.00571	CcSEcCtD
Caffeine—ADORA1—central nervous system—Alzheimer's disease	0.000685	0.00646	CbGeAlD
Caffeine—Convulsion—Memantine—Alzheimer's disease	0.000683	0.00561	CcSEcCtD
Caffeine—Hypertension—Memantine—Alzheimer's disease	0.000681	0.00559	CcSEcCtD
Caffeine—Hypersensitivity—Galantamine—Alzheimer's disease	0.000674	0.00553	CcSEcCtD
Caffeine—ADORA1—cerebellum—Alzheimer's disease	0.00067	0.00632	CbGeAlD
Caffeine—Convulsion—Rivastigmine—Alzheimer's disease	0.000668	0.00549	CcSEcCtD
Caffeine—Hypertension—Rivastigmine—Alzheimer's disease	0.000666	0.00547	CcSEcCtD
Caffeine—Infection—Memantine—Alzheimer's disease	0.000639	0.00525	CcSEcCtD
Caffeine—Dyspnoea—Donepezil—Alzheimer's disease	0.000632	0.00519	CcSEcCtD
Caffeine—Nervous system disorder—Memantine—Alzheimer's disease	0.000631	0.00518	CcSEcCtD
Caffeine—ADORA2A—brain—Alzheimer's disease	0.00063	0.00594	CbGeAlD
Caffeine—Tachycardia—Memantine—Alzheimer's disease	0.000628	0.00516	CcSEcCtD
Caffeine—Infection—Rivastigmine—Alzheimer's disease	0.000625	0.00514	CcSEcCtD
Caffeine—Skin disorder—Memantine—Alzheimer's disease	0.000625	0.00513	CcSEcCtD
Caffeine—Nervous system disorder—Rivastigmine—Alzheimer's disease	0.000617	0.00507	CcSEcCtD
Caffeine—Tachycardia—Rivastigmine—Alzheimer's disease	0.000614	0.00505	CcSEcCtD
Caffeine—Gastrointestinal disorder—Donepezil—Alzheimer's disease	0.000612	0.00503	CcSEcCtD
Caffeine—Skin disorder—Rivastigmine—Alzheimer's disease	0.000611	0.00502	CcSEcCtD
Caffeine—ABCB1—blood vessel—Alzheimer's disease	0.000578	0.00545	CbGeAlD
Caffeine—Rash—Galantamine—Alzheimer's disease	0.000577	0.00474	CcSEcCtD
Caffeine—Dermatitis—Galantamine—Alzheimer's disease	0.000576	0.00473	CcSEcCtD
Caffeine—Dyspnoea—Memantine—Alzheimer's disease	0.000574	0.00471	CcSEcCtD
Caffeine—Dyspnoea—Rivastigmine—Alzheimer's disease	0.000561	0.00461	CcSEcCtD
Caffeine—Gastrointestinal disorder—Memantine—Alzheimer's disease	0.000555	0.00456	CcSEcCtD
Caffeine—ADORA1—brain—Alzheimer's disease	0.000544	0.00513	CbGeAlD
Caffeine—Gastrointestinal disorder—Rivastigmine—Alzheimer's disease	0.000543	0.00446	CcSEcCtD
Caffeine—PDE4B—nervous system—Alzheimer's disease	0.000526	0.00496	CbGeAlD
Caffeine—Hypersensitivity—Donepezil—Alzheimer's disease	0.000522	0.00429	CcSEcCtD
Caffeine—PDE4B—central nervous system—Alzheimer's disease	0.000507	0.00478	CbGeAlD
Caffeine—PDE4B—cerebellum—Alzheimer's disease	0.000495	0.00467	CbGeAlD
Caffeine—CYP2E1—telencephalon—Alzheimer's disease	0.000493	0.00465	CbGeAlD
Caffeine—Hypersensitivity—Memantine—Alzheimer's disease	0.000474	0.00389	CcSEcCtD
Caffeine—Hypersensitivity—Rivastigmine—Alzheimer's disease	0.000464	0.00381	CcSEcCtD
Caffeine—CYP1B1—nervous system—Alzheimer's disease	0.000451	0.00425	CbGeAlD
Caffeine—Rash—Donepezil—Alzheimer's disease	0.000447	0.00367	CcSEcCtD
Caffeine—Dermatitis—Donepezil—Alzheimer's disease	0.000446	0.00367	CcSEcCtD
Caffeine—CYP1B1—central nervous system—Alzheimer's disease	0.000434	0.0041	CbGeAlD
Caffeine—CYP1B1—cerebellum—Alzheimer's disease	0.000425	0.004	CbGeAlD
Caffeine—CYP2D6—forebrain—Alzheimer's disease	0.000424	0.004	CbGeAlD
Caffeine—Rash—Memantine—Alzheimer's disease	0.000406	0.00333	CcSEcCtD
Caffeine—Dermatitis—Memantine—Alzheimer's disease	0.000405	0.00333	CcSEcCtD
Caffeine—PDE4B—brain—Alzheimer's disease	0.000402	0.00379	CbGeAlD
Caffeine—Rash—Rivastigmine—Alzheimer's disease	0.000397	0.00326	CcSEcCtD
Caffeine—Dermatitis—Rivastigmine—Alzheimer's disease	0.000397	0.00326	CcSEcCtD
Caffeine—CYP2D6—telencephalon—Alzheimer's disease	0.00039	0.00368	CbGeAlD
Caffeine—ABCB1—embryo—Alzheimer's disease	0.000345	0.00325	CbGeAlD
Caffeine—CYP1B1—brain—Alzheimer's disease	0.000345	0.00325	CbGeAlD
Caffeine—CYP1A1—nervous system—Alzheimer's disease	0.000319	0.00301	CbGeAlD
Caffeine—CYP1A1—central nervous system—Alzheimer's disease	0.000307	0.0029	CbGeAlD
Caffeine—ABCB1—forebrain—Alzheimer's disease	0.000305	0.00288	CbGeAlD
Caffeine—CYP2E1—nervous system—Alzheimer's disease	0.000291	0.00274	CbGeAlD
Caffeine—ABCB1—telencephalon—Alzheimer's disease	0.000281	0.00265	CbGeAlD
Caffeine—CYP2E1—central nervous system—Alzheimer's disease	0.00028	0.00264	CbGeAlD
Caffeine—CYP2E1—cerebellum—Alzheimer's disease	0.000274	0.00258	CbGeAlD
Caffeine—CYP2C8—brain—Alzheimer's disease	0.000264	0.00249	CbGeAlD
Caffeine—CYP1A1—brain—Alzheimer's disease	0.000244	0.0023	CbGeAlD
Caffeine—CYP3A4—nervous system—Alzheimer's disease	0.000234	0.00221	CbGeAlD
Caffeine—CYP2D6—nervous system—Alzheimer's disease	0.00023	0.00217	CbGeAlD
Caffeine—CYP3A4—central nervous system—Alzheimer's disease	0.000225	0.00212	CbGeAlD
Caffeine—CYP2E1—brain—Alzheimer's disease	0.000222	0.0021	CbGeAlD
Caffeine—CYP2D6—central nervous system—Alzheimer's disease	0.000222	0.00209	CbGeAlD
Caffeine—CYP2D6—cerebellum—Alzheimer's disease	0.000217	0.00204	CbGeAlD
Caffeine—CYP2D6—brain—Alzheimer's disease	0.000176	0.00166	CbGeAlD
Caffeine—ABCB1—nervous system—Alzheimer's disease	0.000166	0.00156	CbGeAlD
Caffeine—ABCB1—central nervous system—Alzheimer's disease	0.000159	0.0015	CbGeAlD
Caffeine—ABCB1—cerebellum—Alzheimer's disease	0.000156	0.00147	CbGeAlD
Caffeine—ABCB1—brain—Alzheimer's disease	0.000127	0.00119	CbGeAlD
Caffeine—ADORA1—GPCR downstream signaling—AKT1—Alzheimer's disease	4.56e-06	1.9e-05	CbGpPWpGaD
Caffeine—PIK3CB—Signaling Pathways—VEGFA—Alzheimer's disease	4.55e-06	1.9e-05	CbGpPWpGaD
Caffeine—ADORA2A—Signaling Pathways—IGF1—Alzheimer's disease	4.53e-06	1.89e-05	CbGpPWpGaD
Caffeine—ADORA1—Signaling Pathways—CASP3—Alzheimer's disease	4.51e-06	1.89e-05	CbGpPWpGaD
Caffeine—ADORA2B—Signaling Pathways—VEGFA—Alzheimer's disease	4.51e-06	1.88e-05	CbGpPWpGaD
Caffeine—PDE4B—GPCR downstream signaling—AKT1—Alzheimer's disease	4.5e-06	1.88e-05	CbGpPWpGaD
Caffeine—PIK3CB—Disease—IL6—Alzheimer's disease	4.49e-06	1.88e-05	CbGpPWpGaD
Caffeine—PIK3CB—Immune System—AKT1—Alzheimer's disease	4.49e-06	1.87e-05	CbGpPWpGaD
Caffeine—CYP3A7—Metabolism—MTHFR—Alzheimer's disease	4.49e-06	1.87e-05	CbGpPWpGaD
Caffeine—ADORA1—Signaling by GPCR—IL6—Alzheimer's disease	4.49e-06	1.87e-05	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism—CHAT—Alzheimer's disease	4.48e-06	1.87e-05	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism—TPI1—Alzheimer's disease	4.48e-06	1.87e-05	CbGpPWpGaD
Caffeine—CYP1A1—Metabolism—PLCB1—Alzheimer's disease	4.47e-06	1.87e-05	CbGpPWpGaD
Caffeine—PDE4B—Signaling Pathways—CASP3—Alzheimer's disease	4.46e-06	1.86e-05	CbGpPWpGaD
Caffeine—PDE4B—Signaling by GPCR—IL6—Alzheimer's disease	4.43e-06	1.85e-05	CbGpPWpGaD
Caffeine—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—Alzheimer's disease	4.39e-06	1.83e-05	CbGpPWpGaD
Caffeine—ABCB1—Metabolism—ACHE—Alzheimer's disease	4.35e-06	1.82e-05	CbGpPWpGaD
Caffeine—CYP2C8—Metabolism—BCHE—Alzheimer's disease	4.35e-06	1.82e-05	CbGpPWpGaD
Caffeine—CYP1A1—Metabolism—ABCA1—Alzheimer's disease	4.34e-06	1.81e-05	CbGpPWpGaD
Caffeine—ABCB1—Metabolism—INPP5D—Alzheimer's disease	4.3e-06	1.79e-05	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism—MAOB—Alzheimer's disease	4.29e-06	1.79e-05	CbGpPWpGaD
Caffeine—PIK3CA—GPCR downstream signaling—AKT1—Alzheimer's disease	4.26e-06	1.78e-05	CbGpPWpGaD
Caffeine—PIK3CA—Signaling Pathways—CASP3—Alzheimer's disease	4.22e-06	1.76e-05	CbGpPWpGaD
Caffeine—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—Alzheimer's disease	4.22e-06	1.76e-05	CbGpPWpGaD
Caffeine—PIK3CA—Signaling by GPCR—IL6—Alzheimer's disease	4.2e-06	1.75e-05	CbGpPWpGaD
Caffeine—CYP3A7—Metabolism—CALM1—Alzheimer's disease	4.19e-06	1.75e-05	CbGpPWpGaD
Caffeine—CYP3A7—Metabolism—APOE—Alzheimer's disease	4.18e-06	1.74e-05	CbGpPWpGaD
Caffeine—PIK3CB—Signaling Pathways—TGFB1—Alzheimer's disease	4.17e-06	1.74e-05	CbGpPWpGaD
Caffeine—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—Alzheimer's disease	4.16e-06	1.74e-05	CbGpPWpGaD
Caffeine—ADORA1—Signaling Pathways—MAPK8—Alzheimer's disease	4.15e-06	1.73e-05	CbGpPWpGaD
Caffeine—PIK3CB—Disease—AKT1—Alzheimer's disease	4.14e-06	1.73e-05	CbGpPWpGaD
Caffeine—CYP3A7—Metabolism—CAV1—Alzheimer's disease	4.14e-06	1.73e-05	CbGpPWpGaD
Caffeine—ADORA1—Signaling by GPCR—AKT1—Alzheimer's disease	4.14e-06	1.73e-05	CbGpPWpGaD
Caffeine—ADORA2B—Signaling Pathways—TGFB1—Alzheimer's disease	4.14e-06	1.73e-05	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism—GAPDH—Alzheimer's disease	4.13e-06	1.73e-05	CbGpPWpGaD
Caffeine—ADORA2A—Signaling Pathways—NOS3—Alzheimer's disease	4.11e-06	1.71e-05	CbGpPWpGaD
Caffeine—CYP2C8—Metabolism—PLCB1—Alzheimer's disease	4.1e-06	1.71e-05	CbGpPWpGaD
Caffeine—PDE4B—Signaling Pathways—MAPK8—Alzheimer's disease	4.1e-06	1.71e-05	CbGpPWpGaD
Caffeine—CYP2D6—Metabolism—ACHE—Alzheimer's disease	4.1e-06	1.71e-05	CbGpPWpGaD
Caffeine—PDE4B—Signaling by GPCR—AKT1—Alzheimer's disease	4.09e-06	1.71e-05	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism of lipids and lipoproteins—APOE—Alzheimer's disease	4.08e-06	1.71e-05	CbGpPWpGaD
Caffeine—ABCB1—Metabolism—ENO1—Alzheimer's disease	4.07e-06	1.7e-05	CbGpPWpGaD
Caffeine—ABCB1—Metabolism—PTGS1—Alzheimer's disease	4.07e-06	1.7e-05	CbGpPWpGaD
Caffeine—CYP2C9—Metabolism—ACHE—Alzheimer's disease	4.06e-06	1.7e-05	CbGpPWpGaD
Caffeine—CYP2D6—Metabolism—INPP5D—Alzheimer's disease	4.05e-06	1.69e-05	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—Alzheimer's disease	4.05e-06	1.69e-05	CbGpPWpGaD
Caffeine—CYP1B1—Metabolism—PPARG—Alzheimer's disease	4.04e-06	1.68e-05	CbGpPWpGaD
Caffeine—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—Alzheimer's disease	4.02e-06	1.68e-05	CbGpPWpGaD
Caffeine—CYP2C9—Metabolism—INPP5D—Alzheimer's disease	4.01e-06	1.68e-05	CbGpPWpGaD
Caffeine—ABCB1—Metabolism—CYP2D6—Alzheimer's disease	4e-06	1.67e-05	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism—A2M—Alzheimer's disease	3.99e-06	1.67e-05	CbGpPWpGaD
Caffeine—PIK3CD—Metabolism—AKT1—Alzheimer's disease	3.98e-06	1.66e-05	CbGpPWpGaD
Caffeine—CYP2C8—Metabolism—ABCA1—Alzheimer's disease	3.98e-06	1.66e-05	CbGpPWpGaD
Caffeine—CYP2E1—Metabolism—PPARGC1A—Alzheimer's disease	3.97e-06	1.66e-05	CbGpPWpGaD
Caffeine—CYP1B1—Metabolism—INS—Alzheimer's disease	3.96e-06	1.65e-05	CbGpPWpGaD
Caffeine—CYP3A5—Metabolism—PPARGC1A—Alzheimer's disease	3.96e-06	1.65e-05	CbGpPWpGaD
Caffeine—CYP2E1—Metabolism—HMOX1—Alzheimer's disease	3.95e-06	1.65e-05	CbGpPWpGaD
Caffeine—PIK3CD—Signaling Pathways—TP53—Alzheimer's disease	3.94e-06	1.65e-05	CbGpPWpGaD
Caffeine—CYP3A5—Metabolism—HMOX1—Alzheimer's disease	3.94e-06	1.64e-05	CbGpPWpGaD
Caffeine—PIK3CA—Signaling Pathways—MAPK8—Alzheimer's disease	3.88e-06	1.62e-05	CbGpPWpGaD
Caffeine—PIK3CA—Signaling by GPCR—AKT1—Alzheimer's disease	3.87e-06	1.62e-05	CbGpPWpGaD
Caffeine—CYP2D6—Metabolism—ENO1—Alzheimer's disease	3.84e-06	1.6e-05	CbGpPWpGaD
Caffeine—CYP2D6—Metabolism—PTGS1—Alzheimer's disease	3.84e-06	1.6e-05	CbGpPWpGaD
Caffeine—PIK3CA—Immune System—IL6—Alzheimer's disease	3.83e-06	1.6e-05	CbGpPWpGaD
Caffeine—ADORA1—Signaling Pathways—VEGFA—Alzheimer's disease	3.83e-06	1.6e-05	CbGpPWpGaD
Caffeine—CYP2C9—Metabolism—PTGS1—Alzheimer's disease	3.81e-06	1.59e-05	CbGpPWpGaD
Caffeine—CYP2C9—Metabolism—ENO1—Alzheimer's disease	3.81e-06	1.59e-05	CbGpPWpGaD
Caffeine—ABCB1—Metabolism—BCHE—Alzheimer's disease	3.79e-06	1.58e-05	CbGpPWpGaD
Caffeine—PDE4B—Signaling Pathways—VEGFA—Alzheimer's disease	3.79e-06	1.58e-05	CbGpPWpGaD
Caffeine—CYP1A1—Metabolism—PPARGC1A—Alzheimer's disease	3.74e-06	1.56e-05	CbGpPWpGaD
Caffeine—CYP2C9—Metabolism—CYP2D6—Alzheimer's disease	3.73e-06	1.56e-05	CbGpPWpGaD
Caffeine—CYP1A1—Metabolism—HMOX1—Alzheimer's disease	3.72e-06	1.55e-05	CbGpPWpGaD
Caffeine—CYP3A7—Metabolism—PPARG—Alzheimer's disease	3.64e-06	1.52e-05	CbGpPWpGaD
Caffeine—CYP2E1—Metabolism—LPL—Alzheimer's disease	3.61e-06	1.51e-05	CbGpPWpGaD
Caffeine—PIK3CD—Signaling Pathways—IL6—Alzheimer's disease	3.61e-06	1.51e-05	CbGpPWpGaD
Caffeine—CYP3A5—Metabolism—LPL—Alzheimer's disease	3.6e-06	1.5e-05	CbGpPWpGaD
Caffeine—PIK3CA—Signaling Pathways—VEGFA—Alzheimer's disease	3.58e-06	1.5e-05	CbGpPWpGaD
Caffeine—ABCB1—Metabolism—PLCB1—Alzheimer's disease	3.57e-06	1.49e-05	CbGpPWpGaD
Caffeine—CYP2D6—Metabolism—BCHE—Alzheimer's disease	3.57e-06	1.49e-05	CbGpPWpGaD
Caffeine—CYP3A7—Metabolism—INS—Alzheimer's disease	3.57e-06	1.49e-05	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—Alzheimer's disease	3.56e-06	1.49e-05	CbGpPWpGaD
Caffeine—PIK3CA—Disease—IL6—Alzheimer's disease	3.54e-06	1.48e-05	CbGpPWpGaD
Caffeine—CYP2C9—Metabolism—BCHE—Alzheimer's disease	3.54e-06	1.48e-05	CbGpPWpGaD
Caffeine—PIK3CA—Immune System—AKT1—Alzheimer's disease	3.54e-06	1.48e-05	CbGpPWpGaD
Caffeine—ADORA2A—GPCR downstream signaling—AKT1—Alzheimer's disease	3.52e-06	1.47e-05	CbGpPWpGaD
Caffeine—ADORA1—Signaling Pathways—TGFB1—Alzheimer's disease	3.52e-06	1.47e-05	CbGpPWpGaD
Caffeine—ADORA2A—Signaling Pathways—CASP3—Alzheimer's disease	3.49e-06	1.46e-05	CbGpPWpGaD
Caffeine—PDE4B—Signaling Pathways—TGFB1—Alzheimer's disease	3.47e-06	1.45e-05	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism—ACHE—Alzheimer's disease	3.47e-06	1.45e-05	CbGpPWpGaD
Caffeine—CYP1B1—Metabolism—NOS3—Alzheimer's disease	3.47e-06	1.45e-05	CbGpPWpGaD
Caffeine—PIK3CB—Metabolism—AKT1—Alzheimer's disease	3.47e-06	1.45e-05	CbGpPWpGaD
Caffeine—ABCB1—Metabolism—ABCA1—Alzheimer's disease	3.46e-06	1.45e-05	CbGpPWpGaD
Caffeine—ADORA2A—Signaling by GPCR—IL6—Alzheimer's disease	3.46e-06	1.45e-05	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—TPI1—Alzheimer's disease	3.45e-06	1.44e-05	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—CHAT—Alzheimer's disease	3.45e-06	1.44e-05	CbGpPWpGaD
Caffeine—PIK3CB—Signaling Pathways—TP53—Alzheimer's disease	3.44e-06	1.43e-05	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism—INPP5D—Alzheimer's disease	3.43e-06	1.43e-05	CbGpPWpGaD
Caffeine—CYP2C8—Metabolism—PPARGC1A—Alzheimer's disease	3.43e-06	1.43e-05	CbGpPWpGaD
Caffeine—CYP2C8—Metabolism—HMOX1—Alzheimer's disease	3.41e-06	1.42e-05	CbGpPWpGaD
Caffeine—ADORA2B—Signaling Pathways—TP53—Alzheimer's disease	3.4e-06	1.42e-05	CbGpPWpGaD
Caffeine—CYP1A1—Metabolism—LPL—Alzheimer's disease	3.4e-06	1.42e-05	CbGpPWpGaD
Caffeine—CYP2D6—Metabolism—PLCB1—Alzheimer's disease	3.37e-06	1.41e-05	CbGpPWpGaD
Caffeine—CYP2C9—Metabolism—PLCB1—Alzheimer's disease	3.34e-06	1.39e-05	CbGpPWpGaD
Caffeine—PIK3CD—Signaling Pathways—AKT1—Alzheimer's disease	3.33e-06	1.39e-05	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—MAOB—Alzheimer's disease	3.31e-06	1.38e-05	CbGpPWpGaD
Caffeine—PIK3CA—Signaling Pathways—TGFB1—Alzheimer's disease	3.29e-06	1.37e-05	CbGpPWpGaD
Caffeine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—Alzheimer's disease	3.28e-06	1.37e-05	CbGpPWpGaD
Caffeine—PIK3CA—Disease—AKT1—Alzheimer's disease	3.27e-06	1.36e-05	CbGpPWpGaD
Caffeine—CYP2D6—Metabolism—ABCA1—Alzheimer's disease	3.26e-06	1.36e-05	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism—ENO1—Alzheimer's disease	3.25e-06	1.36e-05	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism—PTGS1—Alzheimer's disease	3.25e-06	1.36e-05	CbGpPWpGaD
Caffeine—CYP2E1—Metabolism—MTHFR—Alzheimer's disease	3.25e-06	1.36e-05	CbGpPWpGaD
Caffeine—CYP3A5—Metabolism—MTHFR—Alzheimer's disease	3.24e-06	1.35e-05	CbGpPWpGaD
Caffeine—CYP2C9—Metabolism—ABCA1—Alzheimer's disease	3.24e-06	1.35e-05	CbGpPWpGaD
Caffeine—ADORA2A—Signaling Pathways—MAPK8—Alzheimer's disease	3.2e-06	1.34e-05	CbGpPWpGaD
Caffeine—ADORA2A—Signaling by GPCR—AKT1—Alzheimer's disease	3.19e-06	1.33e-05	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism—CYP2D6—Alzheimer's disease	3.19e-06	1.33e-05	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—GAPDH—Alzheimer's disease	3.19e-06	1.33e-05	CbGpPWpGaD
Caffeine—CYP1B1—Metabolism—PTGS2—Alzheimer's disease	3.17e-06	1.33e-05	CbGpPWpGaD
Caffeine—PIK3CB—Signaling Pathways—IL6—Alzheimer's disease	3.15e-06	1.31e-05	CbGpPWpGaD
Caffeine—CYP3A7—Metabolism—NOS3—Alzheimer's disease	3.13e-06	1.31e-05	CbGpPWpGaD
Caffeine—CYP2C8—Metabolism—LPL—Alzheimer's disease	3.12e-06	1.3e-05	CbGpPWpGaD
Caffeine—ADORA2B—Signaling Pathways—IL6—Alzheimer's disease	3.12e-06	1.3e-05	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—A2M—Alzheimer's disease	3.08e-06	1.29e-05	CbGpPWpGaD
Caffeine—CYP1A1—Metabolism—MTHFR—Alzheimer's disease	3.06e-06	1.28e-05	CbGpPWpGaD
Caffeine—CYP2E1—Metabolism—CALM1—Alzheimer's disease	3.04e-06	1.27e-05	CbGpPWpGaD
Caffeine—CYP3A5—Metabolism—CALM1—Alzheimer's disease	3.03e-06	1.27e-05	CbGpPWpGaD
Caffeine—CYP2E1—Metabolism—APOE—Alzheimer's disease	3.03e-06	1.26e-05	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism—BCHE—Alzheimer's disease	3.02e-06	1.26e-05	CbGpPWpGaD
Caffeine—CYP3A5—Metabolism—APOE—Alzheimer's disease	3.02e-06	1.26e-05	CbGpPWpGaD
Caffeine—CYP2E1—Metabolism—CAV1—Alzheimer's disease	3e-06	1.25e-05	CbGpPWpGaD
Caffeine—CYP3A5—Metabolism—CAV1—Alzheimer's disease	2.99e-06	1.25e-05	CbGpPWpGaD
Caffeine—ABCB1—Metabolism—PPARGC1A—Alzheimer's disease	2.99e-06	1.25e-05	CbGpPWpGaD
Caffeine—ABCB1—Metabolism—HMOX1—Alzheimer's disease	2.97e-06	1.24e-05	CbGpPWpGaD
Caffeine—ADORA2A—Signaling Pathways—VEGFA—Alzheimer's disease	2.96e-06	1.24e-05	CbGpPWpGaD
Caffeine—PIK3CB—Signaling Pathways—AKT1—Alzheimer's disease	2.9e-06	1.21e-05	CbGpPWpGaD
Caffeine—ADORA1—Signaling Pathways—TP53—Alzheimer's disease	2.89e-06	1.21e-05	CbGpPWpGaD
Caffeine—ADORA2B—Signaling Pathways—AKT1—Alzheimer's disease	2.87e-06	1.2e-05	CbGpPWpGaD
Caffeine—CYP1A1—Metabolism—CALM1—Alzheimer's disease	2.86e-06	1.2e-05	CbGpPWpGaD
Caffeine—CYP3A7—Metabolism—PTGS2—Alzheimer's disease	2.86e-06	1.2e-05	CbGpPWpGaD
Caffeine—PDE4B—Signaling Pathways—TP53—Alzheimer's disease	2.86e-06	1.19e-05	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism—PLCB1—Alzheimer's disease	2.85e-06	1.19e-05	CbGpPWpGaD
Caffeine—CYP1A1—Metabolism—APOE—Alzheimer's disease	2.85e-06	1.19e-05	CbGpPWpGaD
Caffeine—CYP1A1—Metabolism—CAV1—Alzheimer's disease	2.83e-06	1.18e-05	CbGpPWpGaD
Caffeine—CYP2D6—Metabolism—PPARGC1A—Alzheimer's disease	2.81e-06	1.17e-05	CbGpPWpGaD
Caffeine—CYP2C8—Metabolism—MTHFR—Alzheimer's disease	2.81e-06	1.17e-05	CbGpPWpGaD
Caffeine—CYP2D6—Metabolism—HMOX1—Alzheimer's disease	2.8e-06	1.17e-05	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—Alzheimer's disease	2.8e-06	1.17e-05	CbGpPWpGaD
Caffeine—CYP2C9—Metabolism—PPARGC1A—Alzheimer's disease	2.79e-06	1.16e-05	CbGpPWpGaD
Caffeine—CYP2C9—Metabolism—HMOX1—Alzheimer's disease	2.78e-06	1.16e-05	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism—ABCA1—Alzheimer's disease	2.77e-06	1.15e-05	CbGpPWpGaD
Caffeine—PIK3CA—Metabolism—AKT1—Alzheimer's disease	2.73e-06	1.14e-05	CbGpPWpGaD
Caffeine—ABCB1—Metabolism—LPL—Alzheimer's disease	2.72e-06	1.14e-05	CbGpPWpGaD
Caffeine—ADORA2A—Signaling Pathways—TGFB1—Alzheimer's disease	2.71e-06	1.13e-05	CbGpPWpGaD
Caffeine—PIK3CA—Signaling Pathways—TP53—Alzheimer's disease	2.71e-06	1.13e-05	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—ACHE—Alzheimer's disease	2.68e-06	1.12e-05	CbGpPWpGaD
Caffeine—ADORA1—Signaling Pathways—IL6—Alzheimer's disease	2.65e-06	1.11e-05	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—INPP5D—Alzheimer's disease	2.65e-06	1.11e-05	CbGpPWpGaD
Caffeine—CYP2E1—Metabolism—PPARG—Alzheimer's disease	2.64e-06	1.1e-05	CbGpPWpGaD
Caffeine—CYP3A5—Metabolism—PPARG—Alzheimer's disease	2.63e-06	1.1e-05	CbGpPWpGaD
Caffeine—CYP2C8—Metabolism—CALM1—Alzheimer's disease	2.62e-06	1.1e-05	CbGpPWpGaD
Caffeine—PDE4B—Signaling Pathways—IL6—Alzheimer's disease	2.62e-06	1.09e-05	CbGpPWpGaD
Caffeine—CYP2C8—Metabolism—APOE—Alzheimer's disease	2.62e-06	1.09e-05	CbGpPWpGaD
Caffeine—CYP2C8—Metabolism—CAV1—Alzheimer's disease	2.59e-06	1.08e-05	CbGpPWpGaD
Caffeine—CYP2E1—Metabolism—INS—Alzheimer's disease	2.59e-06	1.08e-05	CbGpPWpGaD
Caffeine—CYP3A5—Metabolism—INS—Alzheimer's disease	2.58e-06	1.08e-05	CbGpPWpGaD
Caffeine—CYP2D6—Metabolism—LPL—Alzheimer's disease	2.56e-06	1.07e-05	CbGpPWpGaD
Caffeine—CYP2C9—Metabolism—LPL—Alzheimer's disease	2.54e-06	1.06e-05	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—PTGS1—Alzheimer's disease	2.51e-06	1.05e-05	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—ENO1—Alzheimer's disease	2.51e-06	1.05e-05	CbGpPWpGaD
Caffeine—CYP1A1—Metabolism—PPARG—Alzheimer's disease	2.48e-06	1.04e-05	CbGpPWpGaD
Caffeine—PIK3CA—Signaling Pathways—IL6—Alzheimer's disease	2.48e-06	1.03e-05	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—CYP2D6—Alzheimer's disease	2.46e-06	1.03e-05	CbGpPWpGaD
Caffeine—ABCB1—Metabolism—MTHFR—Alzheimer's disease	2.45e-06	1.02e-05	CbGpPWpGaD
Caffeine—ADORA1—Signaling Pathways—AKT1—Alzheimer's disease	2.44e-06	1.02e-05	CbGpPWpGaD
Caffeine—CYP1A1—Metabolism—INS—Alzheimer's disease	2.44e-06	1.02e-05	CbGpPWpGaD
Caffeine—PDE4B—Signaling Pathways—AKT1—Alzheimer's disease	2.42e-06	1.01e-05	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism—PPARGC1A—Alzheimer's disease	2.38e-06	9.95e-06	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism—HMOX1—Alzheimer's disease	2.37e-06	9.91e-06	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—BCHE—Alzheimer's disease	2.33e-06	9.74e-06	CbGpPWpGaD
Caffeine—CYP2D6—Metabolism—MTHFR—Alzheimer's disease	2.31e-06	9.63e-06	CbGpPWpGaD
Caffeine—ABCB1—Metabolism—CALM1—Alzheimer's disease	2.29e-06	9.55e-06	CbGpPWpGaD
Caffeine—CYP2C9—Metabolism—MTHFR—Alzheimer's disease	2.29e-06	9.55e-06	CbGpPWpGaD
Caffeine—PIK3CA—Signaling Pathways—AKT1—Alzheimer's disease	2.29e-06	9.55e-06	CbGpPWpGaD
Caffeine—ABCB1—Metabolism—APOE—Alzheimer's disease	2.28e-06	9.51e-06	CbGpPWpGaD
Caffeine—CYP2C8—Metabolism—PPARG—Alzheimer's disease	2.28e-06	9.51e-06	CbGpPWpGaD
Caffeine—CYP2E1—Metabolism—NOS3—Alzheimer's disease	2.27e-06	9.47e-06	CbGpPWpGaD
Caffeine—CYP3A5—Metabolism—NOS3—Alzheimer's disease	2.26e-06	9.45e-06	CbGpPWpGaD
Caffeine—ABCB1—Metabolism—CAV1—Alzheimer's disease	2.26e-06	9.43e-06	CbGpPWpGaD
Caffeine—ADORA2A—Signaling Pathways—TP53—Alzheimer's disease	2.24e-06	9.33e-06	CbGpPWpGaD
Caffeine—CYP2C8—Metabolism—INS—Alzheimer's disease	2.23e-06	9.33e-06	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—PLCB1—Alzheimer's disease	2.2e-06	9.19e-06	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism—LPL—Alzheimer's disease	2.17e-06	9.06e-06	CbGpPWpGaD
Caffeine—CYP2D6—Metabolism—CALM1—Alzheimer's disease	2.15e-06	9e-06	CbGpPWpGaD
Caffeine—CYP2D6—Metabolism—APOE—Alzheimer's disease	2.15e-06	8.97e-06	CbGpPWpGaD
Caffeine—CYP1A1—Metabolism—NOS3—Alzheimer's disease	2.14e-06	8.92e-06	CbGpPWpGaD
Caffeine—CYP2C9—Metabolism—CALM1—Alzheimer's disease	2.14e-06	8.92e-06	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—ABCA1—Alzheimer's disease	2.13e-06	8.91e-06	CbGpPWpGaD
Caffeine—CYP2C9—Metabolism—APOE—Alzheimer's disease	2.13e-06	8.89e-06	CbGpPWpGaD
Caffeine—CYP2D6—Metabolism—CAV1—Alzheimer's disease	2.13e-06	8.88e-06	CbGpPWpGaD
Caffeine—CYP2C9—Metabolism—CAV1—Alzheimer's disease	2.11e-06	8.81e-06	CbGpPWpGaD
Caffeine—CYP2E1—Metabolism—PTGS2—Alzheimer's disease	2.07e-06	8.66e-06	CbGpPWpGaD
Caffeine—CYP3A5—Metabolism—PTGS2—Alzheimer's disease	2.07e-06	8.64e-06	CbGpPWpGaD
Caffeine—ADORA2A—Signaling Pathways—IL6—Alzheimer's disease	2.05e-06	8.54e-06	CbGpPWpGaD
Caffeine—ABCB1—Metabolism—PPARG—Alzheimer's disease	1.98e-06	8.29e-06	CbGpPWpGaD
Caffeine—CYP2C8—Metabolism—NOS3—Alzheimer's disease	1.96e-06	8.18e-06	CbGpPWpGaD
Caffeine—CYP1A1—Metabolism—PTGS2—Alzheimer's disease	1.95e-06	8.16e-06	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism—MTHFR—Alzheimer's disease	1.95e-06	8.16e-06	CbGpPWpGaD
Caffeine—ABCB1—Metabolism—INS—Alzheimer's disease	1.95e-06	8.13e-06	CbGpPWpGaD
Caffeine—ADORA2A—Signaling Pathways—AKT1—Alzheimer's disease	1.89e-06	7.88e-06	CbGpPWpGaD
Caffeine—CYP2D6—Metabolism—PPARG—Alzheimer's disease	1.87e-06	7.81e-06	CbGpPWpGaD
Caffeine—CYP2C9—Metabolism—PPARG—Alzheimer's disease	1.85e-06	7.74e-06	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—PPARGC1A—Alzheimer's disease	1.84e-06	7.68e-06	CbGpPWpGaD
Caffeine—CYP2D6—Metabolism—INS—Alzheimer's disease	1.83e-06	7.66e-06	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—HMOX1—Alzheimer's disease	1.83e-06	7.65e-06	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism—CALM1—Alzheimer's disease	1.83e-06	7.62e-06	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism—APOE—Alzheimer's disease	1.82e-06	7.6e-06	CbGpPWpGaD
Caffeine—CYP2C9—Metabolism—INS—Alzheimer's disease	1.82e-06	7.59e-06	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism—CAV1—Alzheimer's disease	1.8e-06	7.53e-06	CbGpPWpGaD
Caffeine—CYP2C8—Metabolism—PTGS2—Alzheimer's disease	1.79e-06	7.48e-06	CbGpPWpGaD
Caffeine—ABCB1—Metabolism—NOS3—Alzheimer's disease	1.71e-06	7.13e-06	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—LPL—Alzheimer's disease	1.67e-06	6.99e-06	CbGpPWpGaD
Caffeine—CYP2D6—Metabolism—NOS3—Alzheimer's disease	1.61e-06	6.72e-06	CbGpPWpGaD
Caffeine—CYP1B1—Metabolism—AKT1—Alzheimer's disease	1.6e-06	6.66e-06	CbGpPWpGaD
Caffeine—CYP2C9—Metabolism—NOS3—Alzheimer's disease	1.59e-06	6.66e-06	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism—PPARG—Alzheimer's disease	1.58e-06	6.62e-06	CbGpPWpGaD
Caffeine—ABCB1—Metabolism—PTGS2—Alzheimer's disease	1.56e-06	6.52e-06	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism—INS—Alzheimer's disease	1.55e-06	6.49e-06	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—MTHFR—Alzheimer's disease	1.51e-06	6.3e-06	CbGpPWpGaD
Caffeine—CYP2D6—Metabolism—PTGS2—Alzheimer's disease	1.47e-06	6.14e-06	CbGpPWpGaD
Caffeine—CYP2C9—Metabolism—PTGS2—Alzheimer's disease	1.46e-06	6.09e-06	CbGpPWpGaD
Caffeine—CYP3A7—Metabolism—AKT1—Alzheimer's disease	1.44e-06	6.01e-06	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—CALM1—Alzheimer's disease	1.41e-06	5.88e-06	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—APOE—Alzheimer's disease	1.4e-06	5.86e-06	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—CAV1—Alzheimer's disease	1.39e-06	5.81e-06	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism—NOS3—Alzheimer's disease	1.36e-06	5.69e-06	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism—PTGS2—Alzheimer's disease	1.25e-06	5.2e-06	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—PPARG—Alzheimer's disease	1.22e-06	5.11e-06	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—INS—Alzheimer's disease	1.2e-06	5.01e-06	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—NOS3—Alzheimer's disease	1.05e-06	4.39e-06	CbGpPWpGaD
Caffeine—CYP2E1—Metabolism—AKT1—Alzheimer's disease	1.04e-06	4.35e-06	CbGpPWpGaD
Caffeine—CYP3A5—Metabolism—AKT1—Alzheimer's disease	1.04e-06	4.34e-06	CbGpPWpGaD
Caffeine—CYP1A1—Metabolism—AKT1—Alzheimer's disease	9.82e-07	4.1e-06	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—PTGS2—Alzheimer's disease	9.62e-07	4.02e-06	CbGpPWpGaD
Caffeine—CYP2C8—Metabolism—AKT1—Alzheimer's disease	9.01e-07	3.76e-06	CbGpPWpGaD
Caffeine—ABCB1—Metabolism—AKT1—Alzheimer's disease	7.85e-07	3.28e-06	CbGpPWpGaD
Caffeine—CYP2D6—Metabolism—AKT1—Alzheimer's disease	7.39e-07	3.09e-06	CbGpPWpGaD
Caffeine—CYP2C9—Metabolism—AKT1—Alzheimer's disease	7.33e-07	3.06e-06	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism—AKT1—Alzheimer's disease	6.26e-07	2.62e-06	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—AKT1—Alzheimer's disease	4.83e-07	2.02e-06	CbGpPWpGaD
